Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2022

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

Presenter: Omar Abdel-Razek

September 18, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2022

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

Presenter: Dennis Narcisse

September 17, 2022

Presentation TCT 2022

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Presenter: Alexander Fanaroff

September 17, 2022

Presentation ESC 2022

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

Presenter: Axel Bauer

August 28, 2022

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation THT 2022

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Presenter: Mohammed Al-Sadawi

February 01, 2022

Presentation Controversies and Advances 2021

Device Detected Atrial Fibrillation: NOAC or Not?

Presenter: Roopinder K. Sandhu

December 03, 2021

Advertisement

TCT 103: Impact of pre-existing and new atrial fibrillation on major adverse cardiac events following coronary revascularization

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

The Effect of Rhythm vs. Rate Control for Atrial Fibrillation on Mortality and Hospitalization in Patients With Heart Failure With Preserved Ejection Fraction: Updated Meta-Analysis

Device Detected Atrial Fibrillation: NOAC or Not?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content